Body mass index and mortality in CKD

被引:63
|
作者
Madero, Magdalena
Sarnak, Mark J.
Wang, Xuelei
Sceppa, Carmen Castaneda
Greene, Tom
Beck, Gerald J.
Kusek, John W.
Collins, Allan J.
Levey, Andrew S.
Menon, Vandana
机构
[1] Tufts Univ New England Med Ctr, Dept Med, Div Nephrol, Boston, MA 02111 USA
[2] Cleveland Clin Fdn, Dept Biostat & Epidemiol, Cleveland, OH 44195 USA
[3] Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA
[4] Univ Utah, Div Clin Epidemiol, Salt Lake City, UT USA
[5] NIH, Bethesda, MD 20892 USA
[6] Hennepin Cty Med Ctr, Div Nephrol, Minneapolis, MN USA
关键词
kidney disease; outcomes; cardiovascular mortality;
D O I
10.1053/j.ajkd.2007.06.004
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Greater body mass index (BMI) is associated with worse survival in the general population, but appears to confer a survival advantage in patients with kidney failure treated by hemodiaiysis. Data are limited on the relationship of BMI with mortality in patients in the earlier stages of chronic kidney disease (CKD). Study Design: Cohort study. Setting & Participants: The Modification of Diet in Renal Disease (MDRD) Study examined the effects of dietary protein restriction and blood pressure control on progression of kidney disease. This analysis includes 1,759 subjects. Predictor: BMI. Outcomes & Measurements: Cox models were used to evaluate the relationship of quartiles of BMI with all-cause and cardiovascular disease (CVD) mortality. Results: Mean GFR and BMI were 39 +/- 21 (SD) mL/min/1.73 m(2) and 27.1 +/- 4.7 kg/m(2), respectively. During a mean follow-up of 10 years, there were 453 deaths (26%), including 272 deaths (16%) from CVD. In unadjusted Cox models, quartiles 3 (hazard ratio [HR], 1.45; 95% confidence interval [CI], 1.11 to 1.90) and 4 (HR, 1.58; 95% Cl, 1.21 to 2.06) were associated with increased risk of all-cause mortality compared with quartile 1. Adjustment for demographic, CVD, and kidney disease risk factors and randomization status attenuated this relationship for quartiles 3 (HR, 0.81; 95% Cl, 0.60 to 1.09) and 4 (HR, 0.83; 95% Cl, 0.61 to 1.20). In unadjusted Cox models, quartiles 3 (HR, 1.66; 95% Cl, 1.17 to 2.36) and 4 (HR, 1.63; 95% Cl, 1.15 to 2.33) were associated with increased risk of CVD mortality. Multivariable adjustment attenuated this relationship for quartiles 3 (HR, 0.92; 95% Cl, 0.63 to 1.36) and 4 (HR, 0.85; 95% Cl, 0.57 to 1.27). Limitations: Primary analyses were based on single measurement of BMI. Because the MDRD Study cohort included relatively young white subjects with predominantly nondiabetic CKD, results may not be generalizable to all patients with CKD. Conclusions: In this cohort of subjects with predominantly nondiabetic CKD, BMI does not appear to be an independent predictor of all-cause or CKD mortality.
引用
收藏
页码:404 / 411
页数:8
相关论文
共 50 条
  • [1] Body mass index and mortality in CKD: Explaining the obesity paradox
    Tsirpanlis, George
    Petrihou, Christiana
    Savva, Lefkothea
    Sabanis, Nikos
    Frongou, Eleni
    Fotiadou, Vasiliki
    Tsotsorou, Ourania
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2008, 51 (03) : 533 - 533
  • [2] Impact of Misclassification of Obesity by Body Mass Index on Mortality in Patients With CKD
    Lin, Ting-Yun
    Lim, Paik-Seong
    Hung, Szu-Chun
    KIDNEY INTERNATIONAL REPORTS, 2018, 3 (02): : 447 - 455
  • [3] Paradoxical association between body mass index and mortality in men with CKD not yet on dialysis
    Kovesdy, Csaba P.
    Anderson, John E.
    Kalantar-Zadeh, Kamyar
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2007, 49 (05) : 581 - 591
  • [4] Interpretation of Body Mass Index in Children with CKD
    Gao, Tao
    Leonard, Mary B.
    Zemel, Babette
    Kalkwarf, Heidi J.
    Foster, Bethany J.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 7 (04): : 558 - 564
  • [5] Body mass index and mortality
    Woo, Jean
    AGE AND AGEING, 2016, 45 (03) : 331 - 333
  • [6] Association of Body Mass Index with Outcomes in Patients with CKD
    Lu, Jun Ling
    Kalantar-Zadeh, Kamyar
    Ma, Jennie Z.
    Quarles, L. Darryl
    Kovesdy, Csaba P.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2014, 25 (09): : 2088 - 2096
  • [7] Quetelet (Body Mass) Index and Effects of Dapagliflozin in CKD
    Chertow, Glenn M.
    Vart, Priya
    Langkilde, Anna Maria
    McMurray, John
    Correa-Rotter, Ricardo
    Rossing, Peter
    Sjostrom, David
    Stefansson, Bergur V.
    Toto, Robert D.
    Greene, Tom
    Wheeler, David C.
    Heerspink, Hiddo J. L.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 725 - 725
  • [8] Body-mass index and mortality
    Greenberg, James
    LANCET, 2009, 374 (9684): : 113 - 113
  • [9] Body-mass index and mortality
    Durazo-Arvizu, RA
    Goldbourt, U
    McGee, DL
    NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (04): : 287 - 289
  • [10] Body mass index and poststroke mortality
    Olsen, Tom Skyhoj
    Dehlendorff, Christian
    Petersen, Hans Gregers
    Andersen, Klaus Kaae
    NEUROEPIDEMIOLOGY, 2008, 30 (02) : 93 - 100